Viewing SEC Facts Units
Company Name:
NeuBase Therapeutics, Inc.
CIK:
1173281
Start Filing Date:
2014-04-01
End Filing Date:
2014-06-30
ACCN:
0001387131-14-003044
Value:
$ 23,486,785
Value Error:
$ None
Created By:
Date Filed:
2014-08-18
FY:
2014
Fiscal Period:
Q3
Frame:
CY2013Q2
Type:
us-gaap
Form:
10-Q
Units:
shares